Treatment of Recurrent Chlamydia

Understanding Recurrent Infection

The American College of Physicians and other guideline societies note that most recurrent chlamydial infections (84-92%) are reinfections from untreated or new partners, not treatment failures, with treatment failure rates with recommended regimens being extremely low: 0-3% in males and 0-8% in females 2
The high rate of recurrence reflects partner reinfection and sexual network dynamics, not antibiotic resistance, according to the Centers for Disease Control and Prevention (CDC) 3, 4

The CDC recommends treating recurrent chlamydia with the same first-line regimens as initial infection: azithromycin 1 g orally as a single dose or doxycycline 100 mg orally twice daily for 7 days, with azithromycin having an efficacy of approximately 97% and doxycycline having an efficacy of approximately 98% 1, 2
Azithromycin is preferred when compliance is questionable or follow-up is unpredictable, while doxycycline is contraindicated in pregnancy, according to the American College of Obstetricians and Gynecologists (ACOG) 1, 2

The CDC emphasizes that all sexual partners from the preceding 60 days must be evaluated, tested, and treated, with expedited partner therapy considered if partners are unlikely to seek care 3, 4, 1
Patients must abstain from sexual intercourse for 7 days after single-dose therapy or until completion of a 7-day regimen, and until all sex partners have completed treatment, as recommended by the CDC and ACOG 3, 4, 1, 2

The CDC recommends retesting all women with chlamydial infection approximately 3 months after treatment, with repeat infections conferring elevated risk for pelvic inflammatory disease (PID) and other complications compared to initial infection 3, 4, 1, 2
Test-of-cure is generally not recommended unless therapeutic compliance is questionable, symptoms persist, or reinfection is suspected, according to the CDC and ACOG 1, 2, 4

In pregnancy, the recommended regimens are azithromycin 1 g orally as a single dose (preferred) and amoxicillin 500 mg orally three times daily for 7 days, with doxycycline, ofloxacin, and levofloxacin being contraindicated, as noted by ACOG 1, 2, 3, 4
Pregnant women require test-of-cure 3 weeks after treatment completion due to potential maternal and neonatal sequelae, according to the CDC and ACOG 3, 4

Assuming treatment failure when reinfection is more likely, with most recurrences being reinfections from untreated partners, not antibiotic resistance, as emphasized by the CDC 3, 4
Failing to treat sexual partners, which is the single most important factor in preventing recurrent infection, according to the CDC and ACOG 3, 4
Testing too early after treatment, with a recommended wait of at least 3 weeks to avoid false-positives from dead organisms, as noted by the CDC 4
Not retesting women at 3 months, which is a high-risk period for reinfection and elevated PID risk, according to the CDC and ACOG 3, 4
Allowing sexual activity before partner treatment is complete, with both patient and all partners required to complete treatment before resuming intercourse, as recommended by the CDC and ACOG 3, 4, 1, 2